Biotech Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference January 31, 2026
Biotech UT Health San Antonio research shows Alzheimer’s prevention potential in pairing cannabis ingredient, anti-inflammatory drug January 29, 2026
Biotech Nexus Agriscience Acquires Biotech Institute IP Portfolio, Expands Molecular Farming Platform for Natural Ingredient Markets January 27, 2026
Biotech Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes January 26, 2026
Biotech Coating Place Announces Leadership Appointments to Support Next Phase of Growth January 25, 2026
Biotech Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor January 24, 2026
Biotech Next-Generation Sequencing Market worth $29.53 billion by 2030 | MarketsandMarkets™ January 23, 2026